Transparency Reporting New Zealand

Takeda New Zealand Limited has undertaken to be open and transparent in its interactions with the community in which it operates. As a member of Medicines New Zealand, we publish the details of reportable payments or transfers of value to healthcare professionals. Reportable payments or transfers of value are:

• Payments for the provision of services such as giving a lecture, chairing an educational meeting, providing advice as a member of an Advisory Board or as a Consultant;
• Airfares, accommodation and/or conference registration fees provided as part of services as above, or to attend medical education.

The Medicines New Zealand and New Zealand Medical Association (NZMA) Joint Transparency Initiative became effective on 1 January 2021. This initiative aims to promote public confidence in the biopharmaceutical industry through increasing transparency around the interactions between Healthcare Professionals and companies from the innovative medicines sector.

The cornerstone of the Transparency Initiative are the voluntary Guidelines For Disclosure Of Transfers Of Value From Pharmaceutical Companies To Healthcare Professionals which were developed by a joint Working Group composed of representatives from Medicines New Zealand’s Member Companies and the NZMA. For further information, please visit www.medicinesnz.co.nz

To comply with our privacy obligations, the reports may be amended from time to time. The reports here contain the most up to date information. Any use or disclosure of the data by a third party is the responsibility of that third party, which must comply with New Zealand’s Privacy Act 2020.

Takeda New Zealand Limited

Click here for January 2023 – December 2023 PDF